Clinical Trial Update: A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating Hemopatch for air leak control after complex thoracic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Thoracic Air Leak
• Thoracic Surgery

Drugs mentioned

• Hemopatch

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Thoracic Surgery Lung, Post-operative Thoracic Air Leak | Phase 2 | Status: UNKNOWN